RxNorm Semantic Concepts Index
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "".
| RxCUI | Name | Term Type | Term Type Description |
|---|---|---|---|
| Concepts Starting with: 100 | Blood group antibody Weeks | Designated preferred name (PT) | |
| Concepts Starting with: 101 | Substance with direct thrombin inhibitor mechanism of action | Designated preferred name (PT) | |
| Concepts Starting with: 102 | 6-oxoprostaglandin F1 alpha | Designated preferred name (PT) | |
| Concepts Starting with: 103 | 6-mercaptopurine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 104 | Apolipoprotein B | Designated preferred name (PT) | |
| Concepts Starting with: 105 | methysergide 1 MG Oral Tablet [Sansert] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name |
| Concepts Starting with: 106 | Timolol | Designated preferred name (PT) | |
| Concepts Starting with: 107 | Product containing methylprednisolone and neomycin (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. |
| Concepts Starting with: 108 | Trifluoperazine | Designated preferred name (PT) | |
| Concepts Starting with: 109 | avagard (chlorhexidine gluconate 1 % / ethanol 61 % ) Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name |
| Concepts Starting with: 110 | 8-oxyquinol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 111 | Vaginal Cream | Dose Form (DF) | |
| Concepts Starting with: 112 | Vinca alkaloid | Designated preferred name (PT) | |
| Concepts Starting with: 113 | Wax | Designated preferred name (PT) | |
| Concepts Starting with: 114 | Phenol sulfotransferase | Full form of descriptor (FN) | |
| Concepts Starting with: 115 | Ascorbase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 116 | AST - aspartate transaminase | Designated preferred name (PT) | |
| Concepts Starting with: 117 | Alupent Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group |
| Concepts Starting with: 118 | Phenytek Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group |
| Concepts Starting with: 119 | benzethonium Cl 0.15 % / benzocaine 5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 120 | Atenolol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 121 | Adenosine triphosphate (ATP) citrate (pro-3S)-lyase | Designated preferred name (PT) | |
| Concepts Starting with: 122 | Phosphatidylinositol 3-kinase | Designated preferred name (PT) | |
| Concepts Starting with: 123 | biotin / niacinamide / panthenol / zinc pyrithione Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form |
| Concepts Starting with: 124 | Product containing autonomic agent | Designated preferred name (PT) | |
| Concepts Starting with: 125 | ODC - Orotidine-5'-monophosphate decarboxylase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 126 | Home produced spirit | Designated preferred name (PT) | |
| Concepts Starting with: 127 | BIS-EMA | Full form of descriptor (FN) | |
| Concepts Starting with: 128 | Abortifacient agent | Designated preferred name (PT) | |
| Concepts Starting with: 129 | proparacaine hydrochloride 5 MG/ML [Minims Proxymetacaine hydrochloride] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 130 | Siberian elm pollen extract 20000 UNT/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 131 | Picea abies flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 132 | Alpha amino isobutyric acid | Designated preferred name (PT) | |
| Concepts Starting with: 133 | Neomycin palmitate | Designated preferred name (PT) | |
| Concepts Starting with: 134 | Smilax regelii root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 135 | Cascara sagrada bark extract | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 136 | Abrin | Full form of descriptor (FN) | |
| Concepts Starting with: 137 | Lactobacillus acidophilus 10000000000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 138 | 21-deoxycortisol | Full form of descriptor (FN) | |
| Concepts Starting with: 139 | Benzethonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 140 | Caspofungin | Designated preferred name (PT) | |
| Concepts Starting with: 141 | 3,5 T>2< | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 142 | hypromellose 0.5 % / phenylephrine 0.12 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 143 | undecylenic acid 20 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. |
| Concepts Starting with: 144 | miconazole Vaginal Cream [Lagicam] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name |
| Concepts Starting with: 145 | 3-methylfentanyl | Designated preferred name (PT) | |
| Concepts Starting with: 146 | Piperazine derivative | Designated preferred name (PT) | |
| Concepts Starting with: 147 | B endorphin | Designated preferred name (PT) | |
| Concepts Starting with: 148 | Beta-galactosidase | Designated preferred name (PT) | |
| Concepts Starting with: 149 | Acebutolol | Full form of descriptor (FN) | |
| Concepts Starting with: 150 | Hexosaminidase | Designated preferred name (PT) | |
| Concepts Starting with: 151 | Beta very low density lipoprotein | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 152 | Betaxolol | Designated preferred name (PT) | |
| Concepts Starting with: 153 | amiloride hydrochloride 5 MG / furosemide 40 MG Oral Tablet [Frusemek] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name |
| Concepts Starting with: 154 | Nicoumalone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 155 | Acetopromazine | Full form of descriptor (FN) | |
| Concepts Starting with: 156 | Parakeet feathers specific IgE | Designated preferred name (PT) | |
| Concepts Starting with: 157 | Biological substance | Full form of descriptor (FN) | |
| Concepts Starting with: 158 | 5-iodo-2'-deoxycytidine | Designated preferred name (PT) | |
| Concepts Starting with: 159 | palmitamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 160 | camphor 4 % / menthol 10 % / methyl salicylate 30 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 161 | Paracetamol-containing product | Designated preferred name (PT) | |
| Concepts Starting with: 162 | Acetanilid | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 163 | Cholesterol in VLDL, beta | Designated preferred name (PT) | |
| Concepts Starting with: 164 | acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 165 | Acetokinase | Designated preferred name (PT) | |
| Concepts Starting with: 166 | anti-inhibitor coagulant complex Injection [Feiba] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name |
| Concepts Starting with: 167 | Acetazolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 168 | Acetic acid glacial | Designated preferred name (PT) | |
| Concepts Starting with: 169 | Sweet chestnut | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 170 | Orthoboric acid | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 171 | Florical | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 172 | glycerin / petrolatum / phenylephrine / shark liver oil Rectal Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form |
| Concepts Starting with: 173 | Acetohexamide | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. |
| Concepts Starting with: 174 | ciprofloxacin Otic Suspension [Otiprio] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name |
| Concepts Starting with: 175 | 1-hydroxymethyltriazolam | Designated preferred name (PT) | |
| Concepts Starting with: 176 | Diacetyl reductase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 177 | Acetolactate synthase | Designated preferred name (PT) | |
| Concepts Starting with: 178 | Acetone | Designated preferred name (PT) | |
| Concepts Starting with: 179 | Loncor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 180 | Prunus cerasifera whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 181 | sodium hypochlorite 0.62 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 182 | Fatty-acid methyltransferase | Designated preferred name (PT) | |
| Concepts Starting with: 183 | Arogenate dehydrogenase | Designated preferred name (PT) | |
| Concepts Starting with: 184 | Carbohydrate deficient transferrin, asialo fraction | Designated preferred name (PT) | |
| Concepts Starting with: 185 | 2-methylacetoacetyl-CoA thiolase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 186 | 3-ketoacyl-CoA thiolase | Designated preferred name (PT) | |
| Concepts Starting with: 187 | Acetyl-coenzyme A carboxylase | Designated preferred name (PT) | |
| Concepts Starting with: 188 | Acetyl-CoA acylase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 189 | Human leukocyte antigen DRw12 | Designated preferred name (PT) | |
| Concepts Starting with: 190 | 1 biotinyl-CoA synthetase | Designated preferred name (PT) | |
| Concepts Starting with: 191 | calcium hydroxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 192 | Beta-L-arabinosidase | Designated preferred name (PT) | |
| Concepts Starting with: 193 | acetylcarnitine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 194 | Acetylcholine | Designated preferred name (PT) | |
| Concepts Starting with: 195 | Choline esterase I | Full form of descriptor (FN) | |
| Concepts Starting with: 196 | Anticholinesterase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 197 | NAC - N-acetyl cysteine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 198 | nadolol 40 MG / bendroflumethiazide 5 MG Oral Tablet | Designated preferred name (PT) | |
| Concepts Starting with: 199 | acetyldigoxin | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 200 | acetylene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 201 | Acid esterase | Designated preferred name (PT) | |
| Concepts Starting with: 202 | Carbimazole | Full form of descriptor (FN) | |
| Concepts Starting with: 203 | Megace | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 204 | N-Acetyl-beta-glucosaminidase | Full form of descriptor (FN) | |
| Concepts Starting with: 205 | S protein complement | Designated preferred name (PT) | |
| Concepts Starting with: 206 | N-acetylprocainamide | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 207 | Acetylserotonin methyltransferase | Full form of descriptor (FN) | |
| Concepts Starting with: 208 | Corzide 40 MG / 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name |
| Concepts Starting with: 209 | PRED MILD 0.12 % Ophthalmic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name |
| Concepts Starting with: 210 | Acetyltransferase | Full form of descriptor (FN) | |
| Concepts Starting with: 211 | Topicycline | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 212 | Hb 80(EF4), Asp-asn | British preferred term (PTGB) | |
| Concepts Starting with: 213 | chlordiazepoxide hydrochloride 10 MG Oral Capsule [Libritabs] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name |
| Concepts Starting with: 214 | Acid lipase | Designated preferred name (PT) | |
| Concepts Starting with: 215 | Purgative | Full form of descriptor (FN) | |
| Concepts Starting with: 216 | Child Silapap | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 217 | 12 HR dextromethorphan HBr 50 MG / guaifenesin 400 MG / K+ guaiacolsulfonate 200 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. |
| Concepts Starting with: 218 | ceFAZolin | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. |
| Concepts Starting with: 219 | Acid phosphomonoesterase | Full form of descriptor (FN) | |
| Concepts Starting with: 220 | Special C | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 221 | Zartan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 222 | L-3-aminoisobutyrate | Full form of descriptor (FN) | |
| Concepts Starting with: 223 | Cefalexin-containing product | Designated preferred name (PT) | |
| Concepts Starting with: 224 | Simple syrup | Designated preferred name (PT) | |
| Concepts Starting with: 225 | Liquifilm Tears | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 226 | Marcain Heavy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 227 | Ceruloplasmin | British synonym (SYGB) | British synonym of another TTY, given for clarity. |
| Concepts Starting with: 228 | Venombin A | Designated preferred name (PT) | |
| Concepts Starting with: 229 | dichlorobenzyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 230 | Genetically modified virus | Designated preferred name (PT) | |
| Concepts Starting with: 231 | Dihydrodipicolinate synthase | Designated preferred name (PT) | |
| Concepts Starting with: 232 | MCF | Designated preferred name (PT) | |
| Concepts Starting with: 233 | Prostaglandin PGF2 alpha tromethamine | Full form of descriptor (FN) | |
| Concepts Starting with: 234 | dipipanone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 235 | Deoxyribonucleic acid beta-glucosyltransferase | Full form of descriptor (FN) | |
| Concepts Starting with: 236 | acidulated phosphate fluoride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 237 | Levomethadyl | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 238 | estradiol 0.05 MG/Day Weekly Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 239 | Aclarubicin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 240 | Chlorphenamine-containing product | Designated preferred name (PT) | |
| Concepts Starting with: 241 | Aconitase | Designated preferred name (PT) | |
| Concepts Starting with: 242 | aconite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 243 | NH4Cl 200 MG / Guaifenesin 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 244 | Cholesterol desmolase | Designated preferred name (PT) | |
| Concepts Starting with: 245 | Choline acetylase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 246 | Mephobarbital 90 MG / DPH 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 247 | zinc pyrithione 2 MG/ML [Head & Shoulders] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 248 | chloramphenicol 4 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 249 | euflavine | Full form of descriptor (FN) | |
| Concepts Starting with: 250 | Fibrinogen Seattle II | Designated preferred name (PT) | |
| Concepts Starting with: 251 | ketotifen 1 MG / theophylline 200 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 252 | vitamin K3 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 253 | Chymotrypsin A and B | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 254 | Cilastatin | Full form of descriptor (FN) | |
| Concepts Starting with: 255 | Acrosin | Full form of descriptor (FN) | |
| Concepts Starting with: 256 | ephedrine hydrochloride 4.7 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. |
| Concepts Starting with: 257 | Gentamicin acetyltransferase 1 | Designated preferred name (PT) | |
| Concepts Starting with: 258 | Clenbuterol | Full form of descriptor (FN) | |
| Concepts Starting with: 259 | Clobetasol | Designated preferred name (PT) | |
| Concepts Starting with: 260 | Glycerophosphocholine phosphodiesterase | Designated preferred name (PT) | |
| Concepts Starting with: 261 | camphor 5 % / menthol 6 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 262 | Actin-binding protein | Designated preferred name (PT) | |
| Concepts Starting with: 263 | Tositumomab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 264 | Trichomycin | Designated preferred name (PT) | |
| Concepts Starting with: 265 | Cobra venom | Full form of descriptor (FN) | |
| Concepts Starting with: 266 | Coccidioidin | Full form of descriptor (FN) | |
| Concepts Starting with: 267 | Methyl morphine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 268 | Calmera | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 269 | HDL2 - High density lipoprotein subfraction 2 | Designated preferred name (PT) | |
| Concepts Starting with: 270 | Spectinomycin | Full form of descriptor (FN) | |
| Concepts Starting with: 271 | Actin | Designated preferred name (PT) | |
| Concepts Starting with: 272 | Charcoal activated | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 273 | hylan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 274 | Actomyosin | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 275 | Complement component C1 | Full form of descriptor (FN) | |
| Concepts Starting with: 276 | Active C3b | Full form of descriptor (FN) | |
| Concepts Starting with: 277 | C6 - complement component 6 | Full form of descriptor (FN) | |
| Concepts Starting with: 278 | C5b-9 - complement 5b-9 complex | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 279 | isoconazole | Designated preferred name (PT) | |
| Concepts Starting with: 280 | Acute phase reactant | Designated preferred name (PT) | |
| Concepts Starting with: 281 | Aciclovir-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 282 | Ketorolac trometamol | Designated preferred name (PT) | |
| Concepts Starting with: 283 | Acyl coenzyme A | Designated preferred name (PT) | |
| Concepts Starting with: 284 | travoprost 0.004 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 285 | CMPsialate pyrophosphorylase | Designated preferred name (PT) | |
| Concepts Starting with: 286 | LTA-4 hydrolase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 287 | lidamidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 288 | 17,21-hydroxyprogesterone | Designated preferred name (PT) | |
| Concepts Starting with: 289 | Tetracosactide-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 290 | 6-aminopurine | Designated preferred name (PT) | |
| Concepts Starting with: 291 | CKBB - Creatine kinase BB isoenzyme | Designated preferred name (PT) | |
| Concepts Starting with: 292 | Maleylacetate reductase | Designated preferred name (PT) | |
| Concepts Starting with: 293 | Transphosphoribosidase | Designated preferred name (PT) | |
| Concepts Starting with: 294 | Cryoglobulin | Designated preferred name (PT) | |
| Concepts Starting with: 295 | meningococcal group A polysaccharide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 296 | Adenosine | Designated preferred name (PT) | |
| Concepts Starting with: 297 | Cyclandelate | Full form of descriptor (FN) | |
| Concepts Starting with: 298 | N-Methylglutamate synthase | Designated preferred name (PT) | |
| Concepts Starting with: 299 | methylnicotinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 300 | Cyclopenthiazide | Full form of descriptor (FN) | |
| Concepts Starting with: 301 | MMDA | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 302 | mofebutazone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 303 | ADA - Adenosine deaminase | Full form of descriptor (FN) | |
| Concepts Starting with: 304 | ADP | Designated preferred name (PT) | |
| Concepts Starting with: 305 | Protocollagen | Full form of descriptor (FN) | |
| Concepts Starting with: 306 | Cytochrome p-450 enzyme | Designated preferred name (PT) | |
| Concepts Starting with: 307 | etoricoxib | Full form of descriptor (FN) | |
| Concepts Starting with: 308 | Adenosine kinase | Full form of descriptor (FN) | |
| Concepts Starting with: 309 | AMP | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 310 | Actinomycin D | Full form of descriptor (FN) | |
| Concepts Starting with: 311 | DDD | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 312 | ATPase | Designated preferred name (PT) | |
| Concepts Starting with: 313 | sodium chloride 0.9 % Nasal Solution | Full form of descriptor (FN) | |
| Concepts Starting with: 314 | Ca^2+^-transporting adenosine triphosphatase | Full form of descriptor (FN) | |
| Concepts Starting with: 315 | benzalkonium 0.2 MG/ML / chloroxylenol 1 MG/ML / hydrocortisone 10 MG/ML Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 316 | glycopyrrolate 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 317 | Na^+^/K^+^-transporting adenosine triphosphatase | Designated preferred name (PT) | |
| Concepts Starting with: 318 | ATP - Adenosine triphosphate | Designated preferred name (PT) | |
| Concepts Starting with: 319 | nitroxoline | Full form of descriptor (FN) | |
| Concepts Starting with: 320 | Norleucine aminotransferase | Designated preferred name (PT) | |
| Concepts Starting with: 321 | 3',5'-cyclic AMP synthetase | Designated preferred name (PT) | |
| Concepts Starting with: 322 | Myokinase | Designated preferred name (PT) | |
| Concepts Starting with: 323 | Adenylosuccinase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 324 | IMP-aspartate ligase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 325 | Desmopressin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 326 | oxaprozin | Full form of descriptor (FN) | |
| Concepts Starting with: 327 | Dexol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 328 | Palladium chloride | Designated preferred name (PT) | |
| Concepts Starting with: 329 | Dextromoramide | Full form of descriptor (FN) | |
| Concepts Starting with: 330 | methacycline 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 331 | Dialysate | Full form of descriptor (FN) | |
| Concepts Starting with: 332 | Adipex-P | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 333 | adiphenine | Designated preferred name (PT) | |
| Concepts Starting with: 334 | mebendazole 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 335 | Clodronic acid | Full form of descriptor (FN) | |
| Concepts Starting with: 336 | Immunostimulant | Designated preferred name (PT) | |
| Concepts Starting with: 337 | trimipramine 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 338 | rRNA N-glycosidase | Designated preferred name (PT) | |
| Concepts Starting with: 339 | Stilbestrol | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 340 | Digitalis glycoside | Full form of descriptor (FN) | |
| Concepts Starting with: 341 | anidulafungin | Full form of descriptor (FN) | |
| Concepts Starting with: 342 | Polyphosphate kinase | Designated preferred name (PT) | |
| Concepts Starting with: 343 | dihydroxyacetone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 344 | prenylamine lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 345 | GQ1b ganglioside antibody | Full form of descriptor (FN) | |
| Concepts Starting with: 346 | leuprolide 22.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 347 | nitrogen 99.5 % Gas for Inhalation | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 348 | oxygen 99.1 % Gas for Inhalation | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. |
| Concepts Starting with: 349 | lamoTRIgine 2 MG Chewable Dispersible Tablet | Designated preferred name (PT) | |
| Concepts Starting with: 350 | Diphenoxylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 351 | Diphtheria immunoglobulin | Full form of descriptor (FN) | |
| Concepts Starting with: 352 | Diprenorphine | Full form of descriptor (FN) | |
| Concepts Starting with: 353 | Tannic-12 S | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 354 | Adrenal cortical hormone-containing product | Full form of descriptor (FN) | |
| Concepts Starting with: 355 | Ribokinase | Designated preferred name (PT) | |
| Concepts Starting with: 356 | Phosphoribulose epimerase | Designated preferred name (PT) | |
| Concepts Starting with: 357 | Thiazide diuretic | Full form of descriptor (FN) | |
| Concepts Starting with: 358 | roxatidine acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. |
| Concepts Starting with: 359 | Accuzyme 830,000 UNT/GM / 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. |
| Concepts Starting with: 360 | S-Alkylcysteine lyase | Full form of descriptor (FN) | |
| Concepts Starting with: 361 | salicin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 362 | Adrenaline hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 363 | tinzaparin Injectable Solution [Innohep] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name |
| Concepts Starting with: 364 | Doxycycline | Full form of descriptor (FN) | |
| Concepts Starting with: 365 | Sialooligosaccharide | Full form of descriptor (FN) | |
| Concepts Starting with: 366 | Substance with alpha adrenergic receptor agonist mechanism of action | Designated preferred name (PT) | |
| Concepts Starting with: 367 | Substance with alpha adrenergic receptor antagonist mechanism of action | Designated preferred name (PT) | |
| Concepts Starting with: 368 | Beta-1 adrenergic receptor | Full form of descriptor (FN) | |
| Concepts Starting with: 369 | Beta-2 adrenergic receptor | Designated preferred name (PT) | |
| Concepts Starting with: 370 | Substance with beta adrenergic receptor agonist mechanism of action | Full form of descriptor (FN) | |
| Concepts Starting with: 371 | Beta blocker | Full form of descriptor (FN) | |
| Concepts Starting with: 372 | edrophonium Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form |
| Concepts Starting with: 373 | Sucrose glucosyltransferase | Designated preferred name (PT) | |
| Concepts Starting with: 374 | Substance with adrenergic receptor agonist mechanism of action | Designated preferred name (PT) | |
| Concepts Starting with: 375 | Adrenochrome | Designated preferred name (PT) | |
| Concepts Starting with: 376 | Corticotrophin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 377 | calcium iodized / peptone,dried / thyroid (USP) Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form |
| Concepts Starting with: 378 | Elapid venom | Full form of descriptor (FN) | |
| Concepts Starting with: 379 | ascorbic acid / ferrous gluconate / vitamin B12 Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form |
| Concepts Starting with: 380 | Sporothrix species antibody | Full form of descriptor (FN) | |
| Concepts Starting with: 381 | torsemide Oral Tablet [Torem] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name |
| Concepts Starting with: 382 | Emetine | Full form of descriptor (FN) | |
| Concepts Starting with: 383 | Tioxidazole | Full form of descriptor (FN) | |
| Concepts Starting with: 384 | Atomoxetine | Full form of descriptor (FN) | |
| Concepts Starting with: 385 | fluocinonide Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form |
| Concepts Starting with: 386 | fosfestrol Oral Tablet [Honvan] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name |
| Concepts Starting with: 387 | hypromellose 0.32 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 388 | Polymyxin B sulfate | Designated preferred name (PT) | |
| Concepts Starting with: 389 | Mite specific IgG | Designated preferred name (PT) | |
| Concepts Starting with: 390 | IV fluid | Designated preferred name (PT) | |
| Concepts Starting with: 391 | Ubiquitin--protein ligase | Designated preferred name (PT) | |
| Concepts Starting with: 392 | Enflurane | Full form of descriptor (FN) | |
| Concepts Starting with: 393 | Ribonucleic acid uridylyltransferase | Full form of descriptor (FN) | |
| Concepts Starting with: 394 | AFT - Aflatoxin | Full form of descriptor (FN) | |
| Concepts Starting with: 395 | VLDL - Very low density lipoprotein triglyceride | Designated preferred name (PT) | |
| Concepts Starting with: 396 | Substance with enzyme mechanism of action | Full form of descriptor (FN) | |
| Concepts Starting with: 397 | agar | Full form of descriptor (FN) | |
| Concepts Starting with: 398 | Xamoterol | Designated preferred name (PT) | |
| Concepts Starting with: 399 | Epimerase | Designated preferred name (PT) | |
| Concepts Starting with: 400 | Agglutinin | Designated preferred name (PT) | |
| Concepts Starting with: 401 | GP120 V-FMS protein | Full form of descriptor (FN) | |
| Concepts Starting with: 402 | ZOLMitriptan 5 MG/ACTUAT Nasal Spray | Full form of descriptor (FN) | |
| Concepts Starting with: 403 | sulfamethoxazole / trimethoprim Injectable Solution [Bactrim] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name |
| Concepts Starting with: 404 | Eritrityl tetranitrate | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 405 | Dispermox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 406 | Erythrose | Designated preferred name (PT) | |
| Concepts Starting with: 407 | Azinphos-ethyl | Designated preferred name (PT) | |
| Concepts Starting with: 408 | Cricetinae protein | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 409 | Estramustine sodium phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. |
| Concepts Starting with: 410 | Estrogen | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 411 | medical air | Designated preferred name (PT) | |
| Concepts Starting with: 412 | diethylpropion 60 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 413 | Inosine monophosphate cyclohydrolase | Designated preferred name (PT) | |
| Concepts Starting with: 414 | Ethyl biscoumacetate | Designated preferred name (PT) | |
| Concepts Starting with: 415 | Monobasic Pot phosphate 6 MMOL/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 416 | ISOtretinoin 0.00025 MG/MG Topical Gel | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. |
| Concepts Starting with: 417 | Etynodiol diacetate | Designated preferred name (PT) | |
| Concepts Starting with: 418 | Etorphine | Full form of descriptor (FN) | |
| Concepts Starting with: 419 | lidocaine 50 MG/MG / triamcinolone 0.25 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 420 | cefatrizine 100 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 421 | cetrimide 15 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 422 | glycerin 634 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 423 | ajmaline | Full form of descriptor (FN) | |
| Concepts Starting with: 424 | Human platelet antigen | Designated preferred name (PT) | |
| Concepts Starting with: 425 | Activated Christmas Factor | Designated preferred name (PT) | |
| Concepts Starting with: 426 | Alpha-aminopropionic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 427 | ALT - alanine aminotransferase | Designated preferred name (PT) | |
| Concepts Starting with: 428 | Alanine racemase | Full form of descriptor (FN) | |
| Concepts Starting with: 429 | Alanyl-tRNA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 430 | Albendazole | Full form of descriptor (FN) | |
| Concepts Starting with: 431 | buclizine 12.5 MG / Hydroxyzine 10 MG / vit-B3 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 432 | progabide 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 433 | Albumin | Full form of descriptor (FN) | |
| Concepts Starting with: 434 | sulfathiazole 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 435 | Salbutamol-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 436 | lecithin 600 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. |
| Concepts Starting with: 437 | alibendol 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 438 | bromelains 45 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 439 | ADH - Alcohol dehydrogenase | Designated preferred name (PT) | |
| Concepts Starting with: 440 | HLA Ab | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 441 | ketanserin Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form |
| Concepts Starting with: 442 | Fish venom | Full form of descriptor (FN) | |
| Concepts Starting with: 443 | hydroxypropylcellulose 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 444 | Flavoxate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 445 | Fluconazole | Full form of descriptor (FN) | |
| Concepts Starting with: 446 | Flunitrazepam | Designated preferred name (PT) | |
| Concepts Starting with: 447 | oxilofrine 32 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 448 | Ethyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 449 | Fluorometholone | Full form of descriptor (FN) | |
| Concepts Starting with: 450 | Fludroxycortide-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 451 | propafenone 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 452 | theophylline 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 453 | Formaldehyde | Designated preferred name (PT) | |
| Concepts Starting with: 454 | FIGLU | Full form of descriptor (FN) | |
| Concepts Starting with: 455 | Product containing alcohol (product) | Designated preferred name (PT) | |
| Concepts Starting with: 456 | FFP - Fresh frozen plasma | Designated preferred name (PT) | |
| Concepts Starting with: 457 | Fruit sugar | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 458 | Human follicle stimulating hormone | Full form of descriptor (FN) | |
| Concepts Starting with: 459 | Fumarase | Designated preferred name (PT) | |
| Concepts Starting with: 460 | Alcuronium | Full form of descriptor (FN) | |
| Concepts Starting with: 461 | Aldehyde dehydrogenase (nicotinamide adenine dinucleotide ^+^) | Designated preferred name (PT) | |
| Concepts Starting with: 462 | GAG-ONC protein | Full form of descriptor (FN) | |
| Concepts Starting with: 463 | Galactose-1-phosphate uridyl transferase | Full form of descriptor (FN) | |
| Concepts Starting with: 464 | Annexin IV | Designated preferred name (PT) | |
| Concepts Starting with: 465 | Aldehyde-lyase | Full form of descriptor (FN) | |
| Concepts Starting with: 466 | Aldehyde | Designated preferred name (PT) | |
| Concepts Starting with: 467 | Recombinant human soluble insulin | Designated preferred name (PT) | |
| Concepts Starting with: 468 | Basaljel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 469 | benzoxonium chloride | Full form of descriptor (FN) | |
| Concepts Starting with: 470 | Substance with protein kinase inhibitor mechanism of action | Designated preferred name (PT) | |
| Concepts Starting with: 471 | Aldose reductase | Full form of descriptor (FN) | |
| Concepts Starting with: 472 | Blasticidin-S deaminase | Designated preferred name (PT) | |
| Concepts Starting with: 473 | brain-derived neurotrophic factor | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 474 | General anesthetic agents | Full form of descriptor (FN) | |
| Concepts Starting with: 475 | Substance with aldosterone receptor antagonist mechanism of action | Designated preferred name (PT) | |
| Concepts Starting with: 476 | E. coli exonuclease I | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 477 | diphenhydramine citrate 19 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. |
| Concepts Starting with: 478 | Oxytetracycline hydrochloride | Full form of descriptor (FN) | |
| Concepts Starting with: 479 | Alfenta | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 480 | Alfentanil | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. |
| Concepts Starting with: 481 | Thorn | Designated preferred name (PT) | |
| Concepts Starting with: 482 | Clavulanate | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 483 | acetaminophen 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 484 | Walnut tree dust | Full form of descriptor (FN) | |
| Concepts Starting with: 485 | D-glucose | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 486 | chlorothen 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 487 | Glucosidase | Full form of descriptor (FN) | |
| Concepts Starting with: 488 | Glutamate decarboxylase | Designated preferred name (PT) | |
| Concepts Starting with: 489 | L-glutathione | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 490 | Glutathione S-alkyltransferase | Designated preferred name (PT) | |
| Concepts Starting with: 491 | Glycerol | Full form of descriptor (FN) | |
| Concepts Starting with: 492 | Hydrostat | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 493 | Pegintron | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 494 | Alkaline phosphomonoesterase | Designated preferred name (PT) | |
| Concepts Starting with: 495 | Thiocyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 496 | Alkaloid | Full form of descriptor (FN) | |
| Concepts Starting with: 497 | Prialt | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 498 | Aurothioglucose | Full form of descriptor (FN) | |
| Concepts Starting with: 499 | Cottonseed meal toxin | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 500 | Ferrlecit | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 501 | Gramicidin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 502 | Frigiderm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 503 | Guaiacol | Full form of descriptor (FN) | |
| Concepts Starting with: 504 | Alkylating agent | Designated preferred name (PT) | |
| Concepts Starting with: 505 | Dinitroglycerol | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 506 | Goserelin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 507 | halofantrine | Designated preferred name (PT) | |
| Concepts Starting with: 508 | 5-ureidohydantoin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 509 | Haloperidol | Full form of descriptor (FN) | |
| Concepts Starting with: 510 | Harmidine | Designated preferred name (PT) | |
| Concepts Starting with: 511 | Human chorionic gonadotrophin, alpha subunit | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 512 | Hyocholic acid | Full form of descriptor (FN) | |
| Concepts Starting with: 513 | Allethrin | Full form of descriptor (FN) | |
| Concepts Starting with: 514 | He - Helium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 515 | Haematin | Designated preferred name (PT) | |
| Concepts Starting with: 516 | allobarbital | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 517 | Threo 2-amino 3-methylpentanoic acid | Designated preferred name (PT) | |
| Concepts Starting with: 518 | Allophanate hydrolase | Full form of descriptor (FN) | |
| Concepts Starting with: 519 | Allopurinol | Full form of descriptor (FN) | |
| Concepts Starting with: 520 | Allosteric site | Full form of descriptor (FN) | |
| Concepts Starting with: 521 | Hemopexin | Designated preferred name (PT) | |
| Concepts Starting with: 522 | Hemostatic agent | Full form of descriptor (FN) | |
| Concepts Starting with: 523 | Hepatitis antibody | Full form of descriptor (FN) | |
| Concepts Starting with: 524 | manganese gluconate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 525 | Allylestrenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 526 | Methionine aminopeptidase | Designated preferred name (PT) | |
| Concepts Starting with: 527 | Metubine Iodide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 528 | Almitrine | Designated preferred name (PT) | |
| Concepts Starting with: 529 | almitrine dimesylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. |
| Concepts Starting with: 530 | Hexestrol | Designated preferred name (PT) | |
| Concepts Starting with: 531 | Beta-N-acetylhexosaminidase B | Designated preferred name (PT) | |
| Concepts Starting with: 532 | Hexylresorcinol | Designated preferred name (PT) | |
| Concepts Starting with: 533 | Diamine oxidase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 534 | A-1ACT - alpha-1-antichymotrypsin | Designated preferred name (PT) | |
| Concepts Starting with: 535 | AAT - alpha-1-antitrypsin | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 536 | Histone kinase | Designated preferred name (PT) | |
| Concepts Starting with: 537 | nomegestrol acetate | Designated preferred name (PT) | |
| Concepts Starting with: 538 | Human leukocyte antigen A | Full form of descriptor (FN) | |
| Concepts Starting with: 539 | HLA - Human leukocyte antigen B8 | Full form of descriptor (FN) | |
| Concepts Starting with: 540 | A-2M - alpha-2 macroglobulin | Designated preferred name (PT) | |
| Concepts Starting with: 541 | Interferon alfa | Designated preferred name (PT) | |
| Concepts Starting with: 542 | guaifenesin 600 MG / phenylephrine hydrochloride 18 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 543 | Miltuss EX | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 544 | Alpha-fetoglobulin | Designated preferred name (PT) | |
| Concepts Starting with: 545 | Alpha globulin | Full form of descriptor (FN) | |
| Concepts Starting with: 546 | brompheniramine / hydrocodone / pseudoephedrine Oral Solution [Bromplex HD] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. |
| Concepts Starting with: 547 | Hydralazine | Designated preferred name (PT) | |
| Concepts Starting with: 548 | Chlorinated hydrocarbon | Designated preferred name (PT) | |
| Concepts Starting with: 549 | Policresulen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 550 | dibasic potassium phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 551 | Prohormone converting enzyme | Designated preferred name (PT) | |
| Concepts Starting with: 552 | Hydroxychloroquine | Full form of descriptor (FN) | |
| Concepts Starting with: 553 | hydroxyestrones | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 554 | Hydroxymethylglutaryl-coenzyme A synthase | Full form of descriptor (FN) | |
| Concepts Starting with: 555 | Hydroxycarbamide-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 556 | Rhizopus aspartic proteinase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 559 | Hypnotic agent | Full form of descriptor (FN) | |
| Concepts Starting with: 560 | alpha-amylase | Full form of descriptor (FN) | |
| Concepts Starting with: 561 | sennoside B | Designated preferred name (PT) | |
| Concepts Starting with: 562 | cephalexin Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form |
| Concepts Starting with: 563 | pirbuterol 1.5 MG/ML [Exirel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 564 | p-Isobutylhydratropic acid | Designated preferred name (PT) | |
| Concepts Starting with: 565 | Idarubicin | Full form of descriptor (FN) | |
| Concepts Starting with: 566 | Immunoglobulin A1 | Designated preferred name (PT) | |
| Concepts Starting with: 567 | IgG2 - Immunoglobulin G2 | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 568 | ofloxacin 300 MG [Floxin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 569 | Eflornithine | Full form of descriptor (FN) | |
| Concepts Starting with: 570 | acetaminophen 325 MG [Uni-Ace] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 571 | Immunoglobulin fragment | Full form of descriptor (FN) | |
| Concepts Starting with: 572 | Igs - Immunoglobulins | Designated preferred name (PT) | |
| Concepts Starting with: 573 | Lambda light chain | Full form of descriptor (FN) | |
| Concepts Starting with: 574 | estradiol 0.0006 MG/MG [Oestrogel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 575 | Maltase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 576 | ezetimibe 10 MG [Zetia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 577 | estradiol 0.45 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 578 | bromfenac 0.9 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 579 | Minor lactalbumin | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 580 | petrolatum 0.568 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 581 | lactase 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 582 | isopropyl alcohol 0.95 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 583 | Alpha-MSH | Full form of descriptor (FN) | |
| Concepts Starting with: 584 | Infant formula | Full form of descriptor (FN) | |
| Concepts Starting with: 585 | Insulin soluble | Designated preferred name (PT) | |
| Concepts Starting with: 586 | Active C14b2a | Designated preferred name (PT) | |
| Concepts Starting with: 587 | Insulin protease | Full form of descriptor (FN) | |
| Concepts Starting with: 588 | Interferon alfa-2b | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 589 | B-cell growth factor | Designated preferred name (PT) | |
| Concepts Starting with: 590 | Etazocine | Designated preferred name (PT) | |
| Concepts Starting with: 591 | Actiniaria venom | Full form of descriptor (FN) | |
| Concepts Starting with: 592 | IF - Intrinsic factor | Full form of descriptor (FN) | |
| Concepts Starting with: 593 | chromium picolinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 594 | Alphaprodine | Full form of descriptor (FN) | |
| Concepts Starting with: 595 | algestone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 596 | Alprazolam | Designated preferred name (PT) | |
| Concepts Starting with: 597 | Alprenolol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 598 | Prostaglandin PGE1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 599 | Alseroxylon | Designated preferred name (PT) | |
| Concepts Starting with: 600 | Human leucocyte antigen Bw75 | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 601 | Isocarboxazid | Full form of descriptor (FN) | |
| Concepts Starting with: 602 | dorzolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 603 | sodium phosphate 1500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 604 | Hb 22(B4), Glu-gln | Designated preferred name (PT) | |
| Concepts Starting with: 605 | Donatussin MAX | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 606 | Moisture Eyes PM | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 607 | pregabalin 100 MG [Lyrica] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 608 | meperidine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form |
| Concepts Starting with: 609 | tocamphyl | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 610 | Lymphocyte antigen CD66B | Designated preferred name (PT) | |
| Concepts Starting with: 611 | Aluminum aspirin | Full form of descriptor (FN) | |
| Concepts Starting with: 612 | Algeldrate | Full form of descriptor (FN) | |
| Concepts Starting with: 613 | Aluminium hydroxide gel | Full form of descriptor (FN) | |
| Concepts Starting with: 614 | Exjade | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 615 | Aluminium oxide | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 616 | Orencia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 617 | Type IV collagenase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 618 | Kynurenin | Full form of descriptor (FN) | |
| Concepts Starting with: 619 | Amanitotoxin | Full form of descriptor (FN) | |
| Concepts Starting with: 620 | Amantadine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 621 | Amantadine sulfate | Designated preferred name (PT) | |
| Concepts Starting with: 622 | Product containing benzalkonium and cetrimide (medicinal product) | Designated preferred name (PT) | |
| Concepts Starting with: 623 | Ambenonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 624 | Ambestigmine chloride | Full form of descriptor (FN) | |
| Concepts Starting with: 625 | Ambroxol | Full form of descriptor (FN) | |
| Concepts Starting with: 626 | Mecillinam-containing product | Designated preferred name (PT) | |
| Concepts Starting with: 627 | Pivmecillinam-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 628 | Absorbable gelatin sponge | Designated preferred name (PT) | |
| Concepts Starting with: 629 | By Ache | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 630 | hydrofluoric acid 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 631 | citric acid 32.4 MG/ML / magnesium oxide 3.8 MG/ML / sodium carbonate 4.3 MG/ML [Urologic G] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 632 | Mitomycin-C | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 633 | Hemofiltration solution | Full form of descriptor (FN) | |
| Concepts Starting with: 635 | Transamidinase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 636 | Keratol HC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 637 | Levallorphan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 638 | Phosphoribosyldiphosphate 5-amidotransferase | Full form of descriptor (FN) | |
| Concepts Starting with: 639 | Amidotrizoic acid | Designated preferred name (PT) | |
| Concepts Starting with: 640 | linoleic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. |
| Concepts Starting with: 641 | Amikacin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 642 | Lipopolysaccharide | Designated preferred name (PT) | |
| Concepts Starting with: 643 | Amikacin sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. |
| Concepts Starting with: 644 | Amiloride | Designated preferred name (PT) | |
| Concepts Starting with: 645 | Aminoacridine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 646 | fluconazole 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 647 | Lorazepam | Full form of descriptor (FN) | |
| Concepts Starting with: 648 | ferrous fumarate 322 MG / folic acid 350 MCG Oral Tablet | Designated preferred name (PT) | |
| Concepts Starting with: 651 | Lymecycline | Designated preferred name (PT) | |
| Concepts Starting with: 652 | Lymphokine | Full form of descriptor (FN) | |
| Concepts Starting with: 653 | Lypressin | Designated preferred name (PT) | |
| Concepts Starting with: 654 | Ethopropazine hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 655 | acetaminophen / caffeine / salicylamide Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form |
| Concepts Starting with: 656 | Amino-acid racemase | Designated preferred name (PT) | |
| Concepts Starting with: 657 | Mafenide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 658 | Magnesium hydrate | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 659 | Branched-chain amino acid | Full form of descriptor (FN) | |
| Concepts Starting with: 660 | Malic dehydrogenase | Full form of descriptor (FN) | |
| Concepts Starting with: 661 | Cervarix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 662 | Dicarboxylic amino acid | Designated preferred name (PT) | |
| Concepts Starting with: 663 | Essential amino acid | Full form of descriptor (FN) | |
| Concepts Starting with: 664 | Kemstro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 665 | Sulfur-bearing amino acid | Designated preferred name (PT) | |
| Concepts Starting with: 666 | Maxatase | Designated preferred name (PT) | |
| Concepts Starting with: 667 | diethylpropion Extended Release Oral Tablet [Tepanil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name |
| Concepts Starting with: 668 | Medazepam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 669 | Medrogestone | Full form of descriptor (FN) | |
| Concepts Starting with: 670 | linezolid 400 MG Oral Tablet [Zyvox] | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 671 | Melarsoprol | Full form of descriptor (FN) | |
| Concepts Starting with: 672 | chlorpheniramine / hydrocodone / phenylephrine Oral Solution [NUDAL HD] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name |
| Concepts Starting with: 673 | Beta-alanine-oxoglutarate aminotransferase | Designated preferred name (PT) | |
| Concepts Starting with: 674 | Phosphoadenylylsulfatase | British synonym (SYGB) | British synonym of another TTY, given for clarity. |
| Concepts Starting with: 675 | Menthol | Full form of descriptor (FN) | |
| Concepts Starting with: 676 | Meprobamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 677 | Aminoglutethimide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 678 | Aminoglycoside | Full form of descriptor (FN) | |
| Concepts Starting with: 679 | Antigen Ki67 | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 680 | 4-hydroxybenzoate-CoA synthetase | Full form of descriptor (FN) | |
| Concepts Starting with: 681 | piroxicam-beta-cyclodextrin | Full form of descriptor (FN) | |
| Concepts Starting with: 682 | AIB - Aminoisobutyric acid | Designated preferred name (PT) | |
| Concepts Starting with: 683 | ALA - delta-aminolevulinic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 684 | Aminolevulinate dehydratase | Full form of descriptor (FN) | |
| Concepts Starting with: 685 | Aminolevulinate synthase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 686 | Methyclothiazide | Full form of descriptor (FN) | |
| Concepts Starting with: 687 | Peptidase a | Full form of descriptor (FN) | |
| Concepts Starting with: 688 | salicylic acid 0.03 MG/MG [Keralyt] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 689 | Aminophylline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 690 | AQP-2 | Designated preferred name (PT) | |
| Concepts Starting with: 691 | Beta-aminopropionitrile | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 692 | Metrizamide | Designated preferred name (PT) | |
| Concepts Starting with: 693 | ethynodiol / mestranol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. |
| Concepts Starting with: 694 | benzocaine 63 MG/ML [Anbesol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 695 | Aminophenazone | Full form of descriptor (FN) | |
| Concepts Starting with: 696 | Midazolam | Designated preferred name (PT) | |
| Concepts Starting with: 697 | Leucenine | Full form of descriptor (FN) | |
| Concepts Starting with: 698 | Minocycline | Full form of descriptor (FN) | |
| Concepts Starting with: 699 | Misonidazole | Full form of descriptor (FN) | |
| Concepts Starting with: 700 | cider vinegar 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. |
| Concepts Starting with: 701 | Lactobacillus bifidus 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 702 | menthol / methyl salicylate / methylnicotinate Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form |
| Concepts Starting with: 703 | Amiodarone | Designated preferred name (PT) | |
| Concepts Starting with: 704 | Amitriptyline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 705 | cefixime 40 MG/ML [Suprax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 706 | Glucose dehydrogenase | Full form of descriptor (FN) | |
| Concepts Starting with: 707 | Non-human hair - material | Designated preferred name (PT) | |
| Concepts Starting with: 708 | Ammonia-lyase | Designated preferred name (PT) | |
| Concepts Starting with: 709 | ammonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 710 | Product containing codeine and guaiacol (medicinal product) | Designated preferred name (PT) | |
| Concepts Starting with: 711 | Vyvanse | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 712 | Ammonium chloride | Full form of descriptor (FN) | |
| Concepts Starting with: 713 | Erythropoetin delta | Full form of descriptor (FN) | |
| Concepts Starting with: 714 | Product containing cefuroxime and metronidazole (medicinal product) | Designated preferred name (PT) | |
| Concepts Starting with: 715 | Primperan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 716 | Absinthe | Designated preferred name (PT) | |
| Concepts Starting with: 717 | Dioctyl sodium sulfosuccinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. |
| Concepts Starting with: 718 | Myosin adenosine triphosphatase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 719 | Amylobarbitone | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 720 | Amodiaquine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 721 | Arylamine sulfotransferase | Designated preferred name (PT) | |
| Concepts Starting with: 722 | Amoxapine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 723 | Amoxicillin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 724 | AMP aminase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 725 | Amfetamine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 726 | guaiacolsulfonate / HYDROcodone Oral Solution [Atuss EX] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name |
| Concepts Starting with: 727 | Natriuretic hormone | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 728 | Amphibian venom | Designated preferred name (PT) | |
| Concepts Starting with: 729 | Superparamagnetic iron oxide | Designated preferred name (PT) | |
| Concepts Starting with: 730 | Neomycin sulfate | Full form of descriptor (FN) | |
| Concepts Starting with: 731 | aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 732 | Amphotericin B | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 733 | Aminobenzylpenicillin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 734 | O-desmethylvenlafaxine | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 735 | Lysine racemase | Full form of descriptor (FN) | |
| Concepts Starting with: 736 | Depolarizing agent | Full form of descriptor (FN) | |
| Concepts Starting with: 737 | paricalcitol | Full form of descriptor (FN) | |
| Concepts Starting with: 738 | Amrinone-containing product | Full form of descriptor (FN) | |
| Concepts Starting with: 739 | Amsacrine | Full form of descriptor (FN) | |
| Concepts Starting with: 740 | Niclosamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 741 | Treanda | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 742 | Amyl nitrite | Full form of descriptor (FN) | |
| Concepts Starting with: 743 | Amylase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 744 | Nitrazepam | Designated preferred name (PT) | |
| Concepts Starting with: 745 | pantethine 300 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 746 | Amyloid P | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 747 | Pulmozyme | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 748 | AA protein | Full form of descriptor (FN) | |
| Concepts Starting with: 749 | NAD^+^ pyrophosphorylase | Designated preferred name (PT) | |
| Concepts Starting with: 750 | nomifensine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 751 | lamoTRIgine 25 MG Oral Tablet 35 Count Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. |
| Concepts Starting with: 752 | Amylose | Designated preferred name (PT) | |
| Concepts Starting with: 753 | Peranex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 754 | Anabasine | Designated preferred name (PT) | |
| Concepts Starting with: 755 | Nubain | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 756 | Anafranil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 757 | Central nervous system stimulant | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 758 | bismuth subsalicylate 262 MG Chewable Tablet (112) / metroNIDAZOLE 250 MG Oral Tablet (56) / tetracycline HCl 500 MG Oral Capsule (56) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. |
| Concepts Starting with: 759 | prussian blue insoluble 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 760 | Analgesic | Designated preferred name (PT) | |
| Concepts Starting with: 761 | Ochratoxin | Full form of descriptor (FN) | |
| Concepts Starting with: 762 | Kariva 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] |
| Concepts Starting with: 763 | insulin human, rDNA origin Dry Powder Inhaler | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form |
| Concepts Starting with: 764 | Arginine carboxypeptidase | Full form of descriptor (FN) | |
| Concepts Starting with: 765 | Oncoprotein | Full form of descriptor (FN) | |
| Concepts Starting with: 766 | Anaphylatoxin | Full form of descriptor (FN) | |
| Concepts Starting with: 767 | Ophthalmic Solution | Dose Form (DF) | |
| Concepts Starting with: 768 | Synflex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 769 | Anaspaz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 770 | Ornidazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 771 | AGP - alpha-1 acid glycoprotein | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 772 | Agkistrodon serine proteinase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 773 | Nonessential amino acid | Full form of descriptor (FN) | |
| Concepts Starting with: 774 | Osteonectin | Designated preferred name (PT) | |
| Concepts Starting with: 775 | Substance with antiandrogen mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 776 | G-strophanthin | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 777 | Androgen | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 778 | Oxazepam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 779 | Reductase | Designated preferred name (PT) | |
| Concepts Starting with: 780 | Androstane | Designated preferred name (PT) | |
| Concepts Starting with: 781 | HbO2 - Oxyhemoglobin | Full form of descriptor (FN) | |
| Concepts Starting with: 782 | Oxipurinol | Designated preferred name (PT) | |
| Concepts Starting with: 783 | saralasin acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. |
| Concepts Starting with: 784 | ADIONE - delta 4-androstenedione | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 785 | PAI-1 | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 786 | Water soluble vitamin | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 787 | tapentadol | Full form of descriptor (FN) | |
| Concepts Starting with: 788 | Pancreatin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 789 | Sulfacitine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 790 | miconazole Topical Powder [Micatin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name |
| Concepts Starting with: 791 | Paramethasone | Designated preferred name (PT) | |
| Concepts Starting with: 792 | ergonovine 0.2 MG [Ergotrate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 793 | Pargyline | Designated preferred name (PT) | |
| Concepts Starting with: 794 | Parvalbumin | Designated preferred name (PT) | |
| Concepts Starting with: 795 | Corticool | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 796 | Pefloxacin | Full form of descriptor (FN) | |
| Concepts Starting with: 797 | thrombin Topical Solution [Thrombogen] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name |
| Concepts Starting with: 798 | Benzylpenicillin-containing product | Full form of descriptor (FN) | |
| Concepts Starting with: 799 | Cotabflu | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 800 | Dianeal PD-2/4.25 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 801 | Sodium stibogluconate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 802 | Pepsinogen 2 | Designated preferred name (PT) | |
| Concepts Starting with: 803 | chromic chloride 20.5 MCG (chromium 4 MCG) / copper sulfate 1.57 MG (copper 0.4 MG) / manganese sulfate 0.308 MG (manganese 0.1 MG) / zinc sulfate 4.39 MG (zinc 1 MG) per ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 804 | peptones | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 805 | Perhexiline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 806 | Motrin 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 807 | menthol 6.5 MG [Halls] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 808 | pertussis vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 809 | carbidopa 10 MG / levodopa 100 MG [Parcopa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 810 | lacosamide 50 MG Oral Tablet | Designated preferred name (PT) | |
| Concepts Starting with: 811 | phenacetin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 812 | Phenazopyridine | Designated preferred name (PT) | |
| Concepts Starting with: 813 | Phenindione | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 814 | betamethasone / terfenadine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. |
| Concepts Starting with: 815 | Phenprocoumon | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 816 | Phenylbutazone | Designated preferred name (PT) | |
| Concepts Starting with: 817 | Anesthetic | British preferred term (PTGB) | |
| Concepts Starting with: 818 | guaifenesin / pyrilamine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. |
| Concepts Starting with: 819 | Local anesthetic | British preferred term (PTGB) | |
| Concepts Starting with: 820 | Anethole trithione | Designated preferred name (PT) | |
| Concepts Starting with: 821 | Phosphatidate phosphatase | Designated preferred name (PT) | |
| Concepts Starting with: 822 | carisoprodol / dexamethasone / tenoxicam | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. |
| Concepts Starting with: 823 | Phosphopyruvate carboxylase (GTP) | Full form of descriptor (FN) | |
| Concepts Starting with: 824 | Lecithinase A | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 825 | Phosphonacetic acid | Designated preferred name (PT) | |
| Concepts Starting with: 826 | Zn(2+) G peptidase | Full form of descriptor (FN) | |
| Concepts Starting with: 827 | Phosphorylase phosphatase | Full form of descriptor (FN) | |
| Concepts Starting with: 828 | Fosphenytoin sodium | Full form of descriptor (FN) | |
| Concepts Starting with: 829 | methenamine mandelate 500 MG / sodium phosphate, monobasic 500 MG [Utac] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 830 | bicalutamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 831 | Angiotensin 1 | Designated preferred name (PT) | |
| Concepts Starting with: 832 | Nexterone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 833 | desmopressin acetate 0.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 834 | Angiotensin 3 | Designated preferred name (PT) | |
| Concepts Starting with: 835 | Pipradrol | Full form of descriptor (FN) | |
| Concepts Starting with: 836 | Substance with angiotensin-converting enzyme inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 837 | Angiotonase | Full form of descriptor (FN) | |
| Concepts Starting with: 838 | Angiotensinogen | Full form of descriptor (FN) | |
| Concepts Starting with: 839 | Angiotensin | Full form of descriptor (FN) | |
| Concepts Starting with: 840 | Plasma protein | Designated preferred name (PT) | |
| Concepts Starting with: 841 | T-PA | Full form of descriptor (FN) | |
| Concepts Starting with: 842 | Platelet activating factor | Designated preferred name (PT) | |
| Concepts Starting with: 843 | Platelet factor 4 | Designated preferred name (PT) | |
| Concepts Starting with: 844 | Minirin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 845 | carbamazepine 200 MG Extended Release Oral Capsule [Equetro] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. |
| Concepts Starting with: 846 | benzoyl peroxide 5.25 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 847 | vitamin K Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form |
| Concepts Starting with: 848 | Humibid L.A. Reformulated Apr 2009 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 849 | redtop grass pollen extract 100000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 850 | amantadine hydrochloride 100 MG [Mantadine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 851 | Anion exchange resin | Designated preferred name (PT) | |
| Concepts Starting with: 852 | Pectin depolymerase | Full form of descriptor (FN) | |
| Concepts Starting with: 853 | quinidine gluconate 330 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 854 | Polynucleotide phosphorylase | Full form of descriptor (FN) | |
| Concepts Starting with: 855 | benzocaine 15 MG / menthol 4 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. |
| Concepts Starting with: 856 | Polyoxethylene sorbitan oleate | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 857 | PVA - Polyvinyl alcohol | Full form of descriptor (FN) | |
| Concepts Starting with: 858 | Porphyrin | Full form of descriptor (FN) | |
| Concepts Starting with: 859 | guaiacolsulfonate 60 MG/ML / hydrocodone bitartrate 1 MG/ML [Hydone Formula Liquid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name |
| Concepts Starting with: 860 | guaifenesin 60 MG/ML / hydrocodone bitartrate 0.7 MG/ML [Codiclear DH] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. |
| Concepts Starting with: 861 | Anserine | Full form of descriptor (FN) | |
| Concepts Starting with: 862 | Formicidae venom | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 863 | Antacid | Designated preferred name (PT) | |
| Concepts Starting with: 864 | Prednisone | Full form of descriptor (FN) | |
| Concepts Starting with: 865 | Antazoline | Designated preferred name (PT) | |
| Concepts Starting with: 866 | antazoline phosphate | Full form of descriptor (FN) | |
| Concepts Starting with: 867 | Acacia pollen extract 1000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 868 | Substance with anthelmintic mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 869 | Anthocyanin | Designated preferred name (PT) | |
| Concepts Starting with: 870 | Procainamide | Designated preferred name (PT) | |
| Concepts Starting with: 871 | Uridine diphosphate-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 872 | Proflavine | Designated preferred name (PT) | |
| Concepts Starting with: 873 | Dithranol | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 874 | Prolixin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 875 | Phosphoribosyl-anthranilate pyrophosphorylase | Designated preferred name (PT) | |
| Concepts Starting with: 876 | Anthranilate synthase | Designated preferred name (PT) | |
| Concepts Starting with: 877 | propiomazine | Full form of descriptor (FN) | |
| Concepts Starting with: 878 | Propofol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 879 | Product containing propylamine (product) | Designated preferred name (PT) | |
| Concepts Starting with: 880 | Prostaglandin G/H synthase | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 881 | Product containing F series prostaglandin (product) | Full form of descriptor (FN) | |
| Concepts Starting with: 882 | Antirheumatic agent | Full form of descriptor (FN) | |
| Concepts Starting with: 883 | Antiarrhythmic agent | Designated preferred name (PT) | |
| Concepts Starting with: 884 | Anti-infectives | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 885 | Antiseptic agent | Full form of descriptor (FN) | |
| Concepts Starting with: 886 | Proteoglycan | Designated preferred name (PT) | |
| Concepts Starting with: 887 | Antiinflammatory agent | Designated preferred name (PT) | |
| Concepts Starting with: 888 | Protoporphyrin | Full form of descriptor (FN) | |
| Concepts Starting with: 889 | Nonsteroidal anti-inflammatory agent | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 890 | aripiprazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 891 | Calcium Chloride 0.000996 MEQ/ML / Glucose 1.4 MG/ML / Magnesium Chloride 0.0000245 MEQ/ML / NaCl 0.00368 MEQ/ML / Sodium Lactate 0.0016 MEQ/ML Intraperitoneal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 892 | butafosfan 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength |
| Concepts Starting with: 893 | Gamma-glu-X carboxypeptidase | Designated preferred name (PT) | |
| Concepts Starting with: 894 | Pulmonary surfactant | Full form of descriptor (FN) | |
| Concepts Starting with: 895 | Product containing purine nucleoside (product) | Full form of descriptor (FN) | |
| Concepts Starting with: 896 | Antibiotic | Designated preferred name (PT) | |
| Concepts Starting with: 897 | Substance with aminoglycoside structure and antibacterial mechanism of action | Designated preferred name (PT) | |
| Concepts Starting with: 898 | Anthracycline | Designated preferred name (PT) | |
| Concepts Starting with: 899 | sodium bitartrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 900 | Antineoplastic antibiotic | Designated preferred name (PT) | |
| Concepts Starting with: 901 | Pyrimethamine | Designated preferred name (PT) | |
| Concepts Starting with: 902 | pyritinol | Designated preferred name (PT) | |
| Concepts Starting with: 903 | TL-Hist CD | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 904 | Antibody | Full form of descriptor (FN) | |
| Concepts Starting with: 905 | Bifidobacterium infantis 1,000,000,000 UNT per 0.5 GM Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form |
| Concepts Starting with: 906 | ANA | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 907 | Bacterial antibody | Designated preferred name (PT) | |
| Concepts Starting with: 908 | Antibody to fungus | Designated preferred name (PT) | |
| Concepts Starting with: 909 | Helminth antibody | Designated preferred name (PT) | |
| Concepts Starting with: 910 | Heterophile antibody | Full form of descriptor (FN) | |
| Concepts Starting with: 911 | Monoclonal immunoglobulin | Full form of descriptor (FN) | |
| Concepts Starting with: 912 | Replacement preparation | Full form of descriptor (FN) | |
| Concepts Starting with: 913 | Diflorasone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 914 | Viral antibody | Designated preferred name (PT) | |
| Concepts Starting with: 915 | Rattlesnake venom | Designated preferred name (PT) | |
| Concepts Starting with: 916 | Adrenergic receptor | Designated preferred name (PT) | |
| Concepts Starting with: 917 | Complement receptor | Full form of descriptor (FN) | |
| Concepts Starting with: 918 | methyltestosterone 10 MG Oral Tablet [Android-10] | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 919 | Histamine H1 receptor | Full form of descriptor (FN) | |
| Concepts Starting with: 920 | Muscarinic receptor | Full form of descriptor (FN) | |
| Concepts Starting with: 921 | Steroid receptor | Designated preferred name (PT) | |
| Concepts Starting with: 922 | Collyrium Fresh | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 923 | Anticoagulant | Full form of descriptor (FN) | |
| Concepts Starting with: 924 | HYDROmorphone Rectal Suppository [Dilaudid] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. |
| Concepts Starting with: 925 | Drisdol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 926 | Anticonvulsant | Designated preferred name (PT) | |
| Concepts Starting with: 927 | Antidepressant | Full form of descriptor (FN) | |
| Concepts Starting with: 928 | Tricyclic antidepressant | Designated preferred name (PT) | |
| Concepts Starting with: 929 | Antidiarrheal agent | Designated preferred name (PT) | |
| Concepts Starting with: 930 | Antidote | Full form of descriptor (FN) | |
| Concepts Starting with: 931 | Antiemetic agent | Full form of descriptor (FN) | |
| Concepts Starting with: 932 | Mag-Ox 400 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 933 | glyBURIDE Oral Tablet [Micronase] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. |
| Concepts Starting with: 934 | Naphcon forte | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 935 | Nolahist | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 936 | Ophthocort | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 937 | Pediaflor Drops | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 938 | citric acid / potassium citrate Oral Solution [Polycitra-K] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name |
| Concepts Starting with: 939 | medroxyPROGESTERone Oral Tablet [Provera] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name |
| Concepts Starting with: 940 | CIC - Circulating immune complex | Designated preferred name (PT) | |
| Concepts Starting with: 941 | Slo-bid Gyrocaps | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 942 | Sus-Phrine Injection | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 943 | Antigenic determinant | Designated preferred name (PT) | |
| Concepts Starting with: 944 | perphenazine Injectable Solution [Trilafon] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name |
| Concepts Starting with: 945 | methoxamine Injectable Solution [Vasoxyl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name |
| Concepts Starting with: 946 | Antigen | Full form of descriptor (FN) | |
| Concepts Starting with: 947 | Antigen of bacteria | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 948 | Cluster of differentiation antigen | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 949 | Leukocyte 3a | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 950 | Rutoside-containing product | Designated preferred name (PT) | |
| Concepts Starting with: 951 | chloramphenicol Ophthalmic Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form |
| Concepts Starting with: 952 | Salicylanilide | Designated preferred name (PT) | |
| Concepts Starting with: 954 | Antigen of Fungus | Designated preferred name (PT) | |
| Concepts Starting with: 955 | Helminth antigen | Designated preferred name (PT) | |
| Concepts Starting with: 956 | Heterophil antigen | Designated preferred name (PT) | |
| Concepts Starting with: 957 | ichthammol 20 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. |
| Concepts Starting with: 959 | Fibrous protein | Designated preferred name (PT) | |
| Concepts Starting with: 960 | Hyoscine-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 961 | Antigen of Protozoa | Full form of descriptor (FN) | |
| Concepts Starting with: 962 | Quinalbarbitone | Designated preferred name (PT) | |
| Concepts Starting with: 963 | Thymus-independent antigen | Full form of descriptor (FN) | |
| Concepts Starting with: 964 | selenite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 965 | Antigen of virus | Full form of descriptor (FN) | |
| Concepts Starting with: 966 | levothyroxine sodium 0.025 MG Oral Tablet [Eltroxin] | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 967 | Serentil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. |
| Concepts Starting with: 968 | Antihypertensive agent | Designated preferred name (PT) | |
| Concepts Starting with: 969 | miconazole Buccal Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form |
| Concepts Starting with: 970 | Buccal Tablet | Dose Form (DF) | |
| Concepts Starting with: 971 | Anti lymphocyte antibody | Designated preferred name (PT) | |
| Concepts Starting with: 972 | Anas platyrhynchos allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 973 | Antilymphocyte immunoglobulin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 974 | Product containing Salmonella typhimurium antiserum (medicinal product) | Designated preferred name (PT) | |
| Concepts Starting with: 975 | Substance with antimalarial mechanism of action | Designated preferred name (PT) | |
| Concepts Starting with: 976 | Antimetabolite | Designated preferred name (PT) | |
| Concepts Starting with: 977 | N-methyl-L-amino-acid oxidase | Designated preferred name (PT) | |
| Concepts Starting with: 978 | Substance with mitotic inhibitor mechanism of action | Designated preferred name (PT) | |
| Concepts Starting with: 979 | Prephytoene-diphosphate synthase | Full form of descriptor (FN) | |
| Concepts Starting with: 980 | Sincalide | Designated preferred name (PT) | |
| Concepts Starting with: 981 | Antimony potassium tartrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |
| Concepts Starting with: 982 | Nucleoside phosphoacylhydrolase | Designated preferred name (PT) | |
| Concepts Starting with: 983 | Antimony sodium tartrate | Full form of descriptor (FN) | |
| Concepts Starting with: 984 | Substance with muscarinic receptor antagonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 985 | Complement component, precursor | Full form of descriptor (FN) | |
| Concepts Starting with: 986 | Cephalothin sodium | British preferred term (PTGB) | |
| Concepts Starting with: 987 | Blood group antigen Hof | Designated preferred name (PT) | |
| Concepts Starting with: 988 | Antineoplastic agent | Designated preferred name (PT) | |
| Concepts Starting with: 989 | Blood group antibody Boc | Designated preferred name (PT) | |
| Concepts Starting with: 990 | Benzylpenicillin sodium | Full form of descriptor (FN) | |
| Concepts Starting with: 991 | Sodium taurocholate | Designated preferred name (PT) | |
| Concepts Starting with: 992 | Blood group antigen Sp>1< | Synonym (SY) | Synonym of another TTY, given for clarity. |
| Concepts Starting with: 993 | Blood group antibody Pr>a< | Designated preferred name (PT) | |
| Concepts Starting with: 994 | Blood group antigen Haase | Designated preferred name (PT) | |
| Concepts Starting with: 995 | Antiparkinsonian agent | Full form of descriptor (FN) | |
| Concepts Starting with: 996 | Alpha-2-antiplasmin | Full form of descriptor (FN) | |
| Concepts Starting with: 997 | Blood group antibody Cross | Full form of descriptor (FN) | |
| Concepts Starting with: 998 | Substance with antiprotozoal mechanism of action | Designated preferred name (PT) | |
| Concepts Starting with: 999 | Spiperone | Designated preferred name (PT) |